Your browser is no longer supported. Please, upgrade your browser.
Settings
ANGO AngioDynamics Inc. daily Stock Chart
ANGO [NASD]
AngioDynamics Inc.
Index- P/E- EPS (ttm)-0.04 Insider Own0.30% Shs Outstand36.37M Perf Week0.30%
Market Cap491.00M Forward P/E20.33 EPS next Y0.66 Insider Trans-13.10% Shs Float35.11M Perf Month13.45%
Income-1.30M PEG- EPS next Q0.16 Inst Own94.30% Short Float2.60% Perf Quarter10.29%
Sales351.20M P/S1.40 EPS this Y-221.70% Inst Trans1.76% Short Ratio7.60 Perf Half Y7.48%
Book/sh15.24 P/B0.89 EPS next Y18.57% ROA- Target Price13.88 Perf Year-18.67%
Cash/sh0.65 P/C20.80 EPS next 5Y18.00% ROE- 52W Range9.71 - 17.00 Perf YTD11.20%
Dividend- P/FCF- EPS past 5Y-16.90% ROI0.50% 52W High-20.76% Beta0.85
Dividend %- Quick Ratio1.40 Sales past 5Y10.60% Gross Margin50.70% 52W Low38.74% ATR0.45
Employees1300 Current Ratio2.40 Sales Q/Q0.90% Oper. Margin- RSI (14)57.62 Volatility4.12% 3.10%
OptionableYes Debt/Eq0.23 EPS Q/Q114.50% Profit Margin- Rel Volume0.57 Prev Close13.50
ShortableYes LT Debt/Eq0.21 EarningsJul 14 AMC Payout- Avg Volume119.96K Price13.47
Recom2.60 SMA201.96% SMA506.76% SMA20011.39% Volume34,759 Change-0.21%
Apr-08-16Resumed Piper Jaffray Neutral
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Jun-14-11Downgrade Wedbush Neutral → Underperform $14 → $12
Sep-08-10Reiterated Wedbush Neutral $17.50 → $14
Mar-04-10Initiated Wedbush Morgan Neutral $17.50
Sep-04-09Reiterated Caris & Company Above Average $13 → $15
Jul-17-09Reiterated Caris & Company Above Average $15 → $13
Jan-07-09Downgrade Caris & Company Buy → Above Average $20 → $15
Nov-13-08Initiated Stifel Nicolaus Hold
Sep-26-08Initiated Caris & Company Buy $20
Apr-11-08Reiterated Friedman Billings Mkt Perform $14 → $16
Apr-03-08Reiterated Friedman Billings Mkt Perform $16 → $14
Mar-07-08Downgrade Canaccord Adams Buy → Hold $25 → $16
Jun-17-16 05:05PM  ETFs with exposure to AngioDynamics, Inc. : June 17, 2016
Jun-14-16 10:18AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers : June 14, 2016
May-18-16 08:17AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : May 18, 2016
Apr-28-16 12:09PM  PAVmed Inc. (Nasdaq: PAVMU) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
07:15AM  AngioDynamics releases details of ex-CEO's severance package at bizjournals.com
Apr-27-16 04:16PM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Apr-21-16 09:20AM  2 more executives leave one of Albany's biggest public companies at bizjournals.com
09:08AM  New AngioDynamics CEO: I'll focus on current business now, M&A next phase at bizjournals.com
Apr-20-16 08:51AM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Apr-14-16 02:47PM  ETFs with exposure to AngioDynamics, Inc. : April 14, 2016 +6.79%
Apr-13-16 01:59PM  ANGIODYNAMICS INC Financials
09:24AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers
Apr-12-16 03:23PM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : April 12, 2016
Apr-11-16 04:28PM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report
08:15AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : April 11, 2016
Apr-08-16 02:40PM  Thermo Fisher-Siemens Collaborate to Aid Molecular Testing -5.34%
10:00AM  AngioDynamics Tops Q3 Earnings, Sales; FY16 View Pruned
06:02AM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
03:11AM  Edited Transcript of ANGO earnings conference call or presentation 7-Apr-16 8:30pm GMT
Apr-07-16 04:30PM  AngioDynamics Inc Earnings Call scheduled for 4:30 pm ET today
04:07PM  AngioDynamics tops Street 3Q forecasts
04:01PM  AngioDynamics Reports Fiscal 2016 Third Quarter Results GlobeNewswire
07:07AM  Q3 2016 AngioDynamics Inc Earnings Release - After Market Close
Apr-06-16 06:01AM  ANGIODYNAMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securit
Apr-04-16 11:15AM  New CEO named at one of Albany's biggest public companies at bizjournals.com
09:49AM  Can the Uptrend Continue for AngioDynamics (ANGO)?
08:00AM  AngioDynamics Appoints James C. Clemmer as New President and Chief Executive Officer GlobeNewswire
Mar-29-16 06:53AM  AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results at noodls +6.25%
06:30AM  AngioDynamics to Report Fiscal 2016 Third Quarter Financial Results GlobeNewswire
Mar-11-16 10:50AM  Inogen (INGN) Q4 Earnings: A Surprise in the Cards?
Mar-10-16 01:00PM  Add AngioDynamics (ANGO) to Your Portfolio: Here's Why
06:30AM  AngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients GlobeNewswire
Mar-07-16 08:04AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : March 7, 2016
06:30AM  AngioDynamics to Present at the Barclays Global Healthcare Conference GlobeNewswire
Feb-16-16 09:21AM  Strong Investor Participation and Presentations at Long Island Capital Alliance Healthcare Capital Forum Marketwired
Feb-10-16 02:30PM  Gov. Cuomo seeks to reframe $15 billion cost of minimum wage as 'reinvestment' at bizjournals.com
Feb-09-16 04:20PM  AngioDynamics: Health Canada Okays Celerity with Navigation
Feb-08-16 06:30AM  AngioDynamics Announces the Approval of the Celerity PICC Tip Confirmation System With Navigation in Canada GlobeNewswire
Jan-20-16 11:10AM  AngioDynamics, Inc. Earnings Analysis: Q2, 2016 By the Numbers
Jan-13-16 10:28AM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-11-16 12:00PM  Mauna Kea Technologies Announces the Appointment of Joseph DeVivo as a Non-Executive Director PR Newswire
Jan-08-16 04:31PM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report -5.97%
09:35AM  Stocks to Watch: Ford, Bristol-Myers, American Eagle, Alcoa at The Wall Street Journal
09:20AM  AngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut
Jan-07-16 10:32PM  Edited Transcript of ANGO earnings conference call or presentation 7-Jan-16 9:30pm GMT
04:19PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:13PM  AngioDynamics reports 2Q loss
04:01PM  AngioDynamics Reports Fiscal 2016 Second Quarter Results GlobeNewswire
07:07AM  Q2 2016 AngioDynamics Inc Earnings Release - After Market Close
Jan-04-16 06:30AM  AngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference GlobeNewswire
Jan-01-16 08:05AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : January 1, 2016
Dec-28-15 06:30AM  AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results GlobeNewswire
Dec-23-15 08:00AM  Pre-market Insights on Healthcare Sector -- Fluidigm, AngioDynamics, Tandem Diabetes Care, and BioTelemetry Accesswire
Dec-17-15 07:55AM  A Change in Tides - Analyst Notes on Hemisphere Media Group, AngioDynamics, ChemoCentryx and Catalyst Pharmaceuticals Accesswire
Dec-07-15 01:00PM  AngioDynamics: FDA Calls Off Warnings Against Facilities
Dec-03-15 09:44AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : December 3, 2015
07:38AM  Early Global News: American Express Expanding In Russia, Baidu To Merge Its Music Business, China Taking Big Steps To Open Market
06:30AM  FDA Lifts Warning Letters on AngioDynamics Facilities GlobeNewswire
Nov-28-15 11:15AM  Is K12 Inc. (LRN) A Good Stock To Buy? at Insider Monkey
Nov-23-15 06:30AM  AngioDynamics to Present at the Piper Jaffray 27th Annual Healthcare Conference GlobeNewswire
Nov-18-15 04:00PM  AngioDynamics Addresses FDA Warning for NanoKnife System
Nov-17-15 06:30AM  AngioDynamics Announces Resolution of FDA Warning Letter GlobeNewswire
Nov-12-15 08:30AM  How it All Plays Out - Research on SunOpta, Arena Pharmaceuticals, AngioDynamics and Del Taco Restaurants Accesswire
Nov-11-15 06:30AM  AngioDynamics to Present at the 2015 Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire
Nov-09-15 05:30PM  Bragar Eagel & Squire, P.C. Is Investigating the Officers and Directors of AngioDynamics, Inc. (ANGO) on Behalf of Stockholders Business Wire
04:27PM  ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers
08:30AM  AngioDynamics Announces Resignation of CFO and Appointment of Interim CFO GlobeNewswire
08:30AM  Analogic Announces Appointment of Mark Frost as New Chief Financial Officer GlobeNewswire
08:20AM  An Update on Stocks under Momentum - Research on A10 Networks, AngioDynamics, TRAVELCENTERS OF AMERICA and Intersect ENT Accesswire
Nov-06-15 03:42PM  ALERT: Lundin Law PC Announces Investigation of AngioDynamics Inc. And Strongly Advises Shareholders With Losses In Excess of $50,000 To Contact The Firm Business Wire
11:43AM  Glancy Prongay & Murray Commences Investigation on Behalf of AngioDynamics Inc. Investors Business Wire
Nov-03-15 08:30AM  Direction of Market Influences - Research on Cerus, Arena Pharmaceuticals, Walter Investment Management and AngioDynamics Accesswire
Nov-02-15 04:48PM  ANGIODYNAMICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Oct-28-15 06:18PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against AngioDynamics, Inc. and Encourages Investors to Contact the Firm Business Wire
12:35PM  The Wagner Firm Announces Investigation of AngioDynamics, Inc. Business Wire
Oct-21-15 04:45PM  ANGIODYNAMICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stat
Oct-20-15 12:40PM  AngioDynamics Expands in Asia with NanoKnife Approvals
Oct-15-15 04:25PM  ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:00AM  AngioDynamics Announces the Approval of the NanoKnife System in South Korea GlobeNewswire
Oct-12-15 11:03AM  AngioDynamics, Inc. Earnings Q1, 2016
Oct-09-15 09:20AM  AngioDynamics Down on In-Line Q1 Earnings, Sales Miss -6.71%
12:50AM  Edited Transcript of ANGO earnings conference call or presentation 8-Oct-15 8:30pm GMT
Oct-08-15 08:23PM  Thursday's After-Hours Movers Led By Alcoa, Ruby Tuesday, AngioDynamics And Hellen Of Troy Benzinga
05:01PM  ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:39PM  ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report
04:30PM  AngioDynamics Inc Earnings Call scheduled for 4:30 pm ET today
04:11PM  AngioDynamics reports 1Q loss
04:01PM  AngioDynamics Reports Fiscal 2016 First Quarter Results GlobeNewswire
07:07AM  Q1 2016 AngioDynamics Inc Earnings Release - After Market Close
Oct-05-15 09:10AM  Can AngioDynamics' (ANGO) Q1 Earnings Pull a Surprise?
Oct-01-15 06:30AM  AngioDynamics to Report Fiscal 2016 First Quarter Financial Results GlobeNewswire
Sep-08-15 01:45PM  AngioDynamics CEO on why new incentives in health care could benefit his company at bizjournals.com
Sep-02-15 06:30AM  AngioDynamics to Present at the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-13-15 06:30AM  Research Data Published in Annals of Surgery Concludes Irreversible Electroporation Utilizing NanoKnife Results in Substantially Prolonged Survival for Patients With Locally Advanced Pancreatic Cancer Compared With Historical Controls GlobeNewswire
Aug-12-15 08:12PM  10-K for AngioDynamics, Inc. at Company Spotlight
Aug-11-15 06:28PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against AngioDynamics, Inc. on Behalf of Investors Business Wire
Aug-10-15 06:03PM  ANGIODYNAMICS INC Files SEC form 10-K, Annual Report
04:42PM  GPM Announces Expanded Investigation of AngioDynamics, Inc. Business Wire
09:49AM  Boston Scientific Corp. Earnings Q2*, 2015
Aug-06-15 06:30AM  AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database GlobeNewswire
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products for endovascular laser procedures to treat superficial venous diseases; and Sotradecol, a sclerosing drug for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides radiofrequency ablation products that use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors; microwave ablation products; and NanoKnife ablation systems for the surgical ablation of soft tissue The company sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greiner Charles RVP - Global FranchiseMay 06Sale12.313,50843,18320,910May 09 04:05 PM
Trowbridge Stephen ASVP and General CounselApr 25Sale12.182,44029,71930,029Apr 25 06:59 PM
Trowbridge Stephen ASVP and General CounselApr 21Sale12.3310,500129,46532,469Apr 25 06:59 PM
JOHNSON WESLEYDirectorAug 05Option Exercise15.276,00091,62037,574Aug 06 02:05 PM
GOLD JEFFREYDirectorAug 05Option Exercise15.276,00091,62050,411Aug 06 01:58 PM
LaPorte SteveDirectorAug 05Option Exercise15.276,00091,62032,938Aug 06 01:54 PM
Greiner Charles RVP - Global FranchiseAug 05Option Exercise15.2714,100215,30738,676Aug 05 09:48 PM
Trowbridge Stephen ASVP and General CounselAug 05Option Exercise15.275,80088,56649,128Aug 05 09:47 PM
Meteny Dennis SDirectorAug 05Option Exercise15.276,00091,62059,525Aug 07 04:39 PM
DONNELLY HOWARD WDirectorJul 16Option Exercise15.276,00091,62029,659Jul 17 07:02 PM